Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | RARB | P10826 | 11/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | RARA | P10276 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221696 | 1.00 | CYP2C9 (0.57) | CYP2C9ALDH1A1MAPTLMNARARB | |
| Hydrochloric Acid SCHEMBL10971557 | 0.99 | CYP2C9 (0.56) | CYP2C9ALDH1A1MAPTLMNARARB | |
| Hydrochloric Acid SCHEMBL10971561 | 0.99 | CYP2C9 (0.56) | CYP2C9ALDH1A1MAPTLMNARARB | |
| SCHEMBL26364932 | 0.96 | CYP2C9 (0.53) | CYP2C9ALDH1A1MAPTLMNARARB | |
| SCHEMBL17173620 | 0.96 | CYP2C9 (0.58) | CYP2C9ALDH1A1MAPTLMNARARB | |
| SCHEMBL220859 | 0.96 | CYP2C9 (0.61) | CYP2C9ALDH1A1MAPTLMNARARB | |
| SCHEMBL220860 | 0.96 | CYP2C9 (0.61) | CYP2C9ALDH1A1MAPTLMNARARB | |
| SCHEMBL2492365 | 0.94 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNARARB | |
| SCHEMBL9352218 | 0.94 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNARARB | |
| Hydrochloric Acid SCHEMBL8556826 | 0.94 | CYP2C9 (0.59) | CYP2C9ALDH1A1MAPTLMNARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234402-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2025-02-25 | — | — | US | disclosed |
| CN-113122269-B | Ultraviolet light absorber | 光学转变公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20230383187-A1 | Mesogen Compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-11-30 | — | — | US | disclosed |
| US-20230383187-A1 | Mesogen Compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-11-30 | — | — | US | disclosed |
| US-11781070-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-10-10 | — | — | US | disclosed |
| US-11773326-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-10-03 | — | — | US | disclosed |
| US-11773326-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-10-03 | — | — | US | disclosed |
| EP-3894514-B1 | MESOGEN COMPOUNDS | TRANSITIONS OPTICAL LTD (IE) | 2022-11-23 | — | — | EP | disclosed |
| US-20220049161-A1 | Mesogen Compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2022-02-17 | — | — | US | disclosed |
| EP-3894514-A1 | MESOGEN COMPOUNDS | Transitions Optical, Ltd. (IE) | 2021-10-20 | — | — | EP | disclosed |
| US-20110129678-A1 | Photochromic compounds and compositions | TRANSITIONS OPTICAL, INC. (US) | 2011-06-02 | — | — | US | disclosed |
| US-20090176837-A1 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | SONY CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-1907347-A2 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | Arcadia Pharmaceuticals Inc. (US) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007009083-A2 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | ACADIA PHARMACEUTICALS INC. (US) | 2007-01-18 | — | — | WO | disclosed |
| WO-2005095544-A1 | LIQUID CRYSTAL COMPOUNDS, LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2005-10-13 | — | — | WO | disclosed |
| EP-0341713-A2 | Optically active compounds, liquid crystal compositions comprising said compounds, and liquid crystal optical modulators using said compositions | HITACHI, LTD. (JP) | 1989-11-15 | — | — | EP | disclosed |
| US-4708441-A | LIQUID CRYSTALS | HOFFMAN-LA ROCHE INC. (US) | 1987-11-24 | — | — | US | disclosed |
| US-4652089-A | PACKING FOR CHROMATOGRAPHY COLUMNS, ELECTRO-OPTICAL CELLS | HOFFMANN-LA ROCHE INC. (US) | 1987-03-24 | — | — | US | disclosed |
| US-4550981-A | Liquid crystalline esters and mixtures | HOFFMANN-LA ROCHE INC. (US) | 1985-11-05 | — | — | US | disclosed |
| US-4526704-A | Esters containing phenylene and cyclohexylene rings | HOFFMANN-LA ROCHE INC. (US) | 1985-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11781070-B2 | Mesogen compounds | MDN1, LSG1, MNS1 | CYP2C9 4105/4885ALDH1A1 1337/4885MAPT 1511/4885 |
| US-20090176837-A1 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | RARB, RARA, RARG | CYP2C9 4095/4885ALDH1A1 335/4885MAPT 810/4885 |
| US-20110129678-A1 | Photochromic compounds and compositions | CRY2, CRY1, PPOX | CYP2C9 167/4885ALDH1A1 1243/4885MAPT 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.